Any feedback?
Literature summary for 3.1.6.2 extracted from
- Steroid sulfatase in the human MG-63 preosteoblastic cell line Antagonistic regulation by glucocorticoids and NFkappaB (2016), Mol. Cell. Endocrinol., 420, 85-96 .
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| dexamethasone | inhibits STS activity and expression in undifferentiated cells, the glucocorticoid antagonist RU486 reverses dexamethasone inhibition of STS | Homo sapiens |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | P08842 | - |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| MG-63 cell | - |
Homo sapiens | - |
Expression
| Organism | Comment | Expression |
|---|---|---|
| Homo sapiens | STS activity and gene expression are decreased during differentiation in cells treated with osteogenic supplement containing dexamethasone. The NFkappaB activators lipopolysaccharide and phorbol myristate acetate increase STS expression in undifferentiated and differentiated MG-63 cells, while the NFkappaB inhibitor BAY-11-7082 partially blocks these responses | additional information |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
